PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 95 filers reported holding PHATHOM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $80,305 | -34.1% | 7,744 | -9.1% | 0.05% | -31.9% |
| Q2 2023 | $121,935 | -34.8% | 8,515 | -49.5% | 0.07% | -4.0% |
| Q3 2022 | $187,000 | +32.6% | 16,847 | +0.7% | 0.08% | +44.2% |
| Q2 2022 | $141,000 | +20.5% | 16,726 | +95.1% | 0.05% | 0.0% |
| Q1 2022 | $117,000 | -34.6% | 8,575 | -5.6% | 0.05% | -23.5% |
| Q4 2021 | $179,000 | -9.1% | 9,080 | +47.6% | 0.07% | -21.8% |
| Q3 2021 | $197,000 | -10.0% | 6,150 | -5.0% | 0.09% | -3.3% |
| Q2 2021 | $219,000 | -13.8% | 6,476 | -4.1% | 0.09% | -15.9% |
| Q1 2021 | $254,000 | +15.5% | 6,753 | +1.8% | 0.11% | +17.6% |
| Q4 2020 | $220,000 | -3.9% | 6,635 | +6.3% | 0.09% | -24.2% |
| Q3 2020 | $229,000 | -1.7% | 6,242 | -11.8% | 0.12% | +9.1% |
| Q2 2020 | $233,000 | – | 7,076 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $77,669,000 | 45.24% |
| FRAZIER MANAGEMENT LLC | 5,827,415 | $218,878,000 | 17.56% |
| Abingworth LLP | 1,203,135 | $45,057,000 | 15.56% |
| Greenspring Associates, LLC | 360,939 | $13,557,000 | 10.78% |
| Penn Mutual Asset Management, LLC | 86,940 | $3,265,000 | 3.69% |
| RA Capital Management | 3,115,008 | $117,000,000 | 1.76% |
| Rhenman & Partners Asset Management AB | 175,000 | $6,573,000 | 0.46% |
| Summit Rock Advisors, LP | 34,100 | $1,281,000 | 0.44% |
| Eventide Asset Management | 600,000 | $22,536,000 | 0.33% |
| Parkman Healthcare Partners LLC | 30,207 | $1,135,000 | 0.26% |